- Home
- BOLD vs NYC Comparison
BOLD vs NYC Comparison
Compare BOLD & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- NYC
- Stock Information
- Founded
- BOLD 2018
- NYC 2013
- Country
- BOLD United States
- NYC United States
- Employees
- BOLD N/A
- NYC N/A
- Industry
- BOLD
- NYC Real Estate
- Sector
- BOLD
- NYC Finance
- Exchange
- BOLD Nasdaq
- NYC Nasdaq
- Market Cap
- BOLD 30.3M
- NYC 27.6M
- IPO Year
- BOLD 2024
- NYC N/A
- Fundamental
- Price
- BOLD $1.44
- NYC $11.47
- Analyst Decision
- BOLD Hold
- NYC
- Analyst Count
- BOLD 1
- NYC 0
- Target Price
- BOLD N/A
- NYC N/A
- AVG Volume (30 Days)
- BOLD 61.2K
- NYC 5.2K
- Earning Date
- BOLD 05-09-2025
- NYC 05-09-2025
- Dividend Yield
- BOLD N/A
- NYC N/A
- EPS Growth
- BOLD N/A
- NYC N/A
- EPS
- BOLD N/A
- NYC N/A
- Revenue
- BOLD N/A
- NYC $58,397,000.00
- Revenue This Year
- BOLD N/A
- NYC $8.40
- Revenue Next Year
- BOLD N/A
- NYC $1.62
- P/E Ratio
- BOLD N/A
- NYC N/A
- Revenue Growth
- BOLD N/A
- NYC N/A
- 52 Week Low
- BOLD $1.06
- NYC $7.55
- 52 Week High
- BOLD $12.26
- NYC $13.59
- Technical
- Relative Strength Index (RSI)
- BOLD N/A
- NYC 52.12
- Support Level
- BOLD N/A
- NYC $10.68
- Resistance Level
- BOLD N/A
- NYC $11.71
- Average True Range (ATR)
- BOLD 0.00
- NYC 0.58
- MACD
- BOLD 0.00
- NYC -0.05
- Stochastic Oscillator
- BOLD 0.00
- NYC 37.89
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.